<SEC-DOCUMENT>0001171843-19-002459-index.html : 20190417
<SEC-HEADER>0001171843-19-002459.hdr.sgml : 20190417
<ACCEPTANCE-DATETIME>20190417103515
ACCESSION NUMBER:		0001171843-19-002459
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20190417
DATE AS OF CHANGE:		20190417
EFFECTIVENESS DATE:		20190417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOCRYST PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000882796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				621413174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23186
		FILM NUMBER:		19752428

	BUSINESS ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-859-1302

	MAIL ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14a_041719.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
Document 1 - file: defa14a_041719.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>card_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: card_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>card_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: card_2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>card_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: card_3.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>card_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: card_4.jpg

</DOCUMENT>
</SEC-DOCUMENT>